Robert Linhardt
TitelZitiert vonJahr
Heparin–protein interactions
I Capila, RJ Linhardt
Angewandte Chemie International Edition 41 (3), 390-412, 2002
18162002
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
J Schlessinger, AN Plotnikov, OA Ibrahimi, AV Eliseenkova, BK Yeh, ...
Molecular cell 6 (3), 743-750, 2000
11732000
Flexible energy storage devices based on nanocomposite paper
VL Pushparaj, MM Shaijumon, A Kumar, S Murugesan, L Ci, R Vajtai, ...
Proceedings of the National Academy of Sciences 104 (34), 13574-13577, 2007
10552007
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
Y Chen, T Maguire, RE Hileman, JR Fromm, JD Esko, RJ Linhardt, ...
Nature medicine 3 (8), 866, 1997
10181997
Ionic liquid‐mediated selective extraction of lignin from wood leading to enhanced enzymatic cellulose hydrolysis
SH Lee, TV Doherty, RJ Linhardt, JS Dordick
Biotechnology and bioengineering 102 (5), 1368-1376, 2009
8652009
Heparin structure and interactions with basic fibroblast growth factor
S Faham, RE Hileman, JR Fromm, RJ Linhardt, DC Rees
SCIENCE, 1116-1119, 1996
8641996
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone
J Folkman, R Langer, RJ Linhardt, C Haudenschild, S Taylor
Science 221 (4612), 719-725, 1983
7621983
Glycosaminoglycan‐protein interactions: definition of consensus sites in glycosaminoglycan binding proteins
RE Hileman, JR Fromm, JM Weiler, RJ Linhardt
Bioessays 20 (2), 156-167, 1998
6061998
Heparin oligosaccharides bind L-and P-selectin and inhibit acute inflammation
RM Nelson, O Cecconi, WG Roberts, A Aruffo, RJ Linhardt, ...
Blood 82 (11), 3253-3258, 1993
5991993
Polysaccharides: structural diversity and functional versatility
S Dumitriu
CRC press, 2004
5912004
Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate
H Barth, C Schäfer, MI Adah, F Zhang, RJ Linhardt, H Toyoda, ...
Journal of Biological Chemistry 278 (42), 41003-41012, 2003
5632003
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
M Guerrini, D Beccati, Z Shriver, A Naggi, K Viswanathan, A Bisio, I Capila, ...
Nature biotechnology 26 (6), 669, 2008
5532008
Production and chemical processing of low molecular weight heparins
RJ Linhardt, NS Gunay
Seminars in thrombosis and hemostasis 25 (3), 5-16, 1999
4821999
Recent advances in stereoselective c-glycoside synthesis
Y Du, RJ Linhardt, IR Vlahov
Tetrahedron 54 (34), 9913-9959, 1998
4621998
2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity
RJ Linhardt
Journal of medicinal chemistry 46 (13), 2551-2564, 2003
4372003
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
R Goetz, A Beenken, OA Ibrahimi, J Kalinina, SK Olsen, AV Eliseenkova, ...
Molecular and cellular biology 27 (9), 3417-3428, 2007
4352007
Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as …
A Koenig, K Norgard-Sumnicht, R Linhardt, A Varki
The Journal of clinical investigation 101 (4), 877-889, 1998
4201998
Room temperature ionic liquids as emerging solvents for the pretreatment of lignocellulosic biomass
M Mora‐Pale, L Meli, TV Doherty, RJ Linhardt, JS Dordick
Biotechnology and bioengineering 108 (6), 1229-1245, 2011
3552011
Polysaccharide lyases
RJ Linhardt, PM Galliher, CL Cooney
Applied biochemistry and biotechnology 12 (2), 135-176, 1987
3341987
Lessons learned from the contamination of heparin
H Liu, Z Zhang, RJ Linhardt
Natural product reports 26 (3), 313-321, 2009
3102009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20